Literature DB >> 22468996

Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients.

Christina Jorup-Rönström1, Anders Håkanson, Staffan Sandell, Ove Edvinsson, Tore Midtvedt, Anna-Karin Persson, Elisabeth Norin.   

Abstract

Clostridium difficile-associated disease (CDAD) with frequent watery stools, sometimes with painful bowel movements, fever and sickness, is probably the major known cause of antibiotic-associated diarrhea and colitis, most probably depending on a disruption of the normal intestinal balance in the microbiome. In this study, we have inoculated a mixture of fecal microbes--as an enema--originating from a healthy Scandinavian middle-aged donor, regularly re-cultivated under strict anaerobic conditions for more than 10 years, to 32 patients. Twenty-two patients (69%) were durably cured. In those patients receiving the transplant by colonoscopy, four out of five were cured. To the best of our knowledge, this is the first time a fecal culture of microbes has retained the possibility for years to cure a substantial number of patients with CDAD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22468996     DOI: 10.3109/00365521.2012.672587

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  29 in total

Review 1.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

2.  Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy.

Authors:  Paul Moayyedi; John K Marshall; Yuhong Yuan; Richard Hunt
Journal:  Can J Gastroenterol Hepatol       Date:  2014-02

Review 3.  Clinical update for the diagnosis and treatment of Clostridium difficile infection.

Authors:  Edward C Oldfield; Edward C Oldfield; David A Johnson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

4.  Clinical Relevance of Gastrointestinal Microbiota During Pregnancy: A Primer for Nurses.

Authors:  Seon-Yoon Chung; Jacques Ravel; Mary Regan
Journal:  Biol Res Nurs       Date:  2017-09-27       Impact factor: 2.522

Review 5.  Clostridium difficile infection: guideline-based diagnosis and treatment.

Authors:  Christoph Lübbert; Endres John; Lutz von Müller
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

6.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 7.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

8.  What are We Learning and What Can We Learn from the Human Oral Microbiome Project?

Authors:  Benjamin Cross; Roberta C Faustoferri; Robert G Quivey
Journal:  Curr Oral Health Rep       Date:  2016-01-23

9.  The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters.

Authors:  Kjersti Aagaard; Joseph Petrosino; Wendy Keitel; Mark Watson; James Katancik; Nathalia Garcia; Shital Patel; Mary Cutting; Tessa Madden; Holli Hamilton; Emily Harris; Dirk Gevers; Gina Simone; Pamela McInnes; James Versalovic
Journal:  FASEB J       Date:  2012-11-19       Impact factor: 5.191

Review 10.  The gut microbiota in transplant patients.

Authors:  Pearlie P Chong; Andrew Y Koh
Journal:  Blood Rev       Date:  2019-08-29       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.